Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

China flag China · Delayed Price · Currency is CNY
15.89
-0.09 (-0.56%)
Mar 4, 2026, 9:35 AM CST
-36.69%
Market Cap 38.25B
Revenue (ttm) 10.91B
Net Income (ttm) -1.31B
Shares Out 2.39B
EPS (ttm) -0.55
PE Ratio n/a
Forward PE 11.11
Dividend 0.20 (1.20%)
Ex-Dividend Date n/a
Volume 2,265,700
Average Volume 25,193,477
Open 17.23
Previous Close 15.98
Day's Range 15.76 - 17.23
52-Week Range 15.89 - 26.23
Beta 0.66
RSI 33.41
Earnings Date Apr 28, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China. The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysacchar... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7,220
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300122
Full Company Profile

Financial Performance

In 2024, SHE:300122's revenue was 26.07 billion, a decrease of -50.74% compared to the previous year's 52.92 billion. Earnings were 2.02 billion, a decrease of -74.99%.

Financial Statements

News

There is no news available yet.